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Background: Niemann-Pick disease type C (NP-C) is a fatal lysosomal neurodegenerative and neurovisceral disease.
It is caused by defects in intracellular lipid trafficking, which lead to the accumulation of lipids and
glycosphingolipids within the endosomes and lysosomes of affected individuals. Pathogenic variants of the NPC1 or
NPC2 genes yield highly variable phenotypes with a time course that ranges from fetal onset (i.e., hydrops fetalis) to
progressive dementia in adults. NP-C is typically inherited in an autosomal-recessive manner. To our knowledge, no
previous report has identified germline mosaicism as an inheritance mechanism in NP-C.
Case presentation: We report the case of a male Mexican patient with “variant” filipin staining and a juvenile form
of NP-C attributed to compound heterozygosity for two previously reported pathogenic variants of NPC1:
c.[1042C>T];[2780C>T] or p.[Arg348*];[Ala927Val]. The proband’s mother and healthy sister were heterozygous
carriers of the c.2780C > T (exon 18) and c.1042C > T (exon 8) variants, respectively. However, direct sequencing of
exons 8 and 18 of NPC1 revealed no mutation in genomic DNA obtained from the father’s peripheral blood. DNA
profiling ruled out the possibility of non-paternity. We were unable to obtain a sperm sample to demonstrate
paternal gonadal mosaicism. NPC1 haplotype analysis using 20 linked single nucleotide variants failed to yield
sufficient information to document a p.(Arg348*) NPC1 pathogenic variant-associated haplotype in the family.
Conclusions: We propose that this case of NP-C involves paternal germline mosaicism. To the best of our
knowledge, this has not previously been reported in NP-C.
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mutationsBackground
Niemann-Pick disease type C (NP-C, MIM#257220) is
a fatal neurovisceral lipid lysosomal storage disorder
characterized by progressive neurological deterioration
and premature death [1, 2]. The incidence of NP-C in
European populations is about 1 in 120,000 newborns
[1]. The disease is usually considered to be pan-ethnic,
but its incidence is unknown in the Mexican population* Correspondence: gcervera@teleton.org.mx
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terol: a defect in intracellular lipid trafficking leads to the
accumulation of cholesterol and glycosphingolipids within
the endosomal compartments and lysosomes of affected
individuals [1–4].
NP-C is caused by mutations in the NPC1 (95 %) and
NPC2 genes (5 %), and is classically inherited with an
autosomal-recessive pattern [1]. The NPC1 gene
(18q11.2) spans 55.1 kb, includes 25 exons, and encodes
the 13-transmembrane-domain NPC1 protein, which
comprises 1,278 amino acids and is primarily localized
to late endosomes [1, 3]. To date, nearly 60le is distributed under the terms of the Creative Commons Attribution 4.0
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tations have been identified in NPC1; of the latter, most
(~70 %) are missense pathogenic variants that affect the
cysteine-rich luminal domain and lead to variable clin-
ical presentations [1, 2, 5].
The large number of compound heterozygous patients
has made it difficult for researchers to determine any
genotype-phenotype correlation for NP-C. However,
genetic testing of each newly diagnosed patient and his/
her first-degree relatives is highly advisable. The ob-
tained information can be used to establish specific re-
currence risks, identify carriers, offer prenatal diagnosis,
and exclude uncommon inheritance mechanisms, such
as the potential germline mosaicism identified in the
present family.Case presentation
The proband was a 19-year-old boy of Mexican an-
cestry born from healthy non-consanguineous par-
ents (Fig. 1). His clinical manifestations and analytic
results are presented in Table 1, along with those
previously reported in patients harboring at least one
NPC1 gene mutation in common with our patient
[5–8]. His symptomatology initiated at 9 years old
with progressive clumsiness; over the next six years,
he developed cataplexy, progressive dysarthria,
ataxia, fatigue and problems swallowing liquids. He
had to leave school because of learning difficulties,
memory loss, and impaired socialization. A clinical
suspicion of NP-C at 18 years of age prompted a filipin
staining test that yielded a “variant” phenotype [4]. Further
molecular analyses confirmed the diagnosis of NP-C by
exhibiting compound heterozygosity of NPC1: c.[1042C >
T];[2780C >T] or p.[Arg348*];[Ala927Val] (Fig. 1). These
pathogenic variants are located in exons 8 and 18, respect-
ively, of the NPC1 gene (Genbank reference sequence:
NM_000271.4).
To provide the family with complete genetic counsel-
ing, we performed direct automated sequencing of
exons 8 and 18 of the NPC1 gene in genomic DNA ob-
tained from blood leukocytes of the proband’s parents
and healthy older sister (Fig. 1). The mother was found
to be a heterozygous carrier of the c.2780C > T or
p.(Ala927Val) NPC1 allele located in exon 18. The
healthy sister was found to be a heterozygous carrier of
the c.1042C > T or p.(Arg348*) pathogenic variant in
exon 8. Surprisingly, the father’s sample was not found
to have any mutation in these exons. Paternity testing
performed using 16 short tandem repeat markers (13
belonging to the CODIS system) confirmed the pater-
nity of both siblings (data not shown).
To test whether the c.1042C >T or p.(Arg348*) variant
shared a common NPC1 haplotype, we subjected 20 closelylinked or intragenic NPC1 single nucleotide variants (tel-
rs1620047, rs1652354, rs182004416, rs2981422, rs2303880,
rs1623003, rs1788781, rs1367084, rs12970899, rs143656971,
rs1805081, rs1652344, rs1788799, rs1805082, rs1140458,
rs6507720, rs367911777, rs55724504, rs2510344, rs1805084-
cen) to direct automated sequencing in all family members.
Unfortunately, only the genotypes of markers rs182004416
(NM_000271.4:c.-1002A >G, 5′ end of NPC1), rs1623003
(NM_000271.4:c.57 + 1088G >A, intron 1) and rs12970899
(NM_000271.4:c.387T >C, exon 4) provided sufficient
information to document phases in the family, and
the analysis failed to identify a common haplotype for
this pathogenic variant. Our results suggest the pres-
ence of a recombination event between markers
rs1623003 and rs12970899 in the proband or his
healthy carrier sister. Alternatively (though far less
likely), the p.(Arg348*) variant could reside in differ-
ent haplotypes of these two individuals (Fig. 1).
The patient died at 21 years of age due to respiratory
distress secondary to bronchopneumonia. At the time of
death, he scored 22 points on a modified disability scale
for NP-C [9]. He had not received specific substrate-
reduction therapy (Zavesca®, Miglustat) because the fam-
ily could not afford the treatment.Conclusions
NP-C exhibits marked clinical variability and often re-
mains undetected for many years, with an average delay
in diagnosis of 5–6 years from the onset of neurological
symptoms [10]. Consistent with this, our patient first ex-
hibited symptomatology at 9 years of age but was not di-
agnosed with a clinical suspicion of NP-C for another
9 years. He exhibited the classical clinical manifestations
of the juvenile form of the disease when he was exam-
ined at 18 years of age. His index suspicion score at
diagnosis was 142 points (>70 points is highly suspicious
for NP-C) [11].
Our molecular study of the patient’s first-degree rela-
tives showed that the c.1042C > T or p.(Arg348*) and
c.2780C > T or p.(Ala927Val) pathogenic variants resided
in different NPC1 alleles, confirming the compound het-
erozygous status diagnostic for NP-C. The c.2780C > T
or p.(Ala927Val) is a missense transition-type pathogenic
variant that affects the third endoluminal cysteine-rich
domain of the protein, where most of the NP-C-causing
mutations have been described [1, 2, 5]. A homozygous
c.2780C > T or p.(Ala927Val) NP-C-affected male patient
of Arab Muslim ancestry was previously reported [5].
This individual presented a clinical picture similar to
that of the present case (Table 1), including the presence
of mild splenomegaly and ataxia. Another report de-
scribed a family with three cases of adult NP-C, all of
whom were homozygous for c.2780C > T [7]; similar to
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Fig. 1 Pedigree of the described NP-C case, partial electropherograms (forward strands) of exons 8 and 18 of NPC1, and haplotype analysis of
family members using the three informative intragenic markers. Sanger automated DNA sequencing of the entire coding sequence of NPC1 in
the proband (II-2) revealed the heterozygous compound genotype, c.[1042C > T];[2780C > T] or p.[Arg348*];[Ala927Val] (reference NPC1 sequence:
NM_000271.4). This result was confirmed using a second genomic DNA blood sample from II-2. To determine allelic segregation, we directly examined
both pathogenic variants in leukocyte-derived genomic DNA obtained from the proband’s parents (I-1 and I-2) and healthy sibling (II-1). Obligate
carrier status was confirmed in I-2, who was heterozygous for the NPC1 c.2780C > T or p.(Ala927Val) (exon 18) variant, and II-1 was found to be an
obligate carrier for the NPC1 c.1042C > T or p.(Arg348*) (exon 8) variant. We assume the latter variant is of paternal origin, but it was not detected by
automated bidirectional sequencing of total blood leukocyte-derived genomic DNA from I-1. Paternity testing through DNA profiling clearly confirmed
the paternity of both siblings (data not shown). Our haplotype analysis failed to identify a common paternal haplotype for this mutation, although it
did suggest the presence of a paternal recombination event (rec?). However, our molecular findings are consistent with the presence of paternal
germline mosaicism for the c.1042C > T or p.(Arg348*) pathogenic variant. WT: wild-type NPC1 allele
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staining, splenomegaly, and cognitive impairment. Based
on the present and prior observations, we conclude that
the juvenile/adult form of NP-C associated with the
c.2780C > T mutation usually manifests with a “variant”
filipin staining phenotype (Table 1).
The c.1042C > T or p.(Arg348*) mutation is a non-
sense transition-type variation that was previously re-
ported as a pathogenic variant [8, 12]. Interestingly, this
mutation was also reported in a female Mexican patient
who had a confirmed diagnosis of NP-C, a juvenile pres-
entation, and a clinical picture very similar to that de-
scribed herein [8]. Unlike the present case, however, no
molecular study was performed to confirm that both
parents were obligate carriers [8].
NP-C was previously thought to show strictly classical
autosomal-recessive inheritance, with both parents being
obligate carriers of the disease. Our current results suggest
the presence of paternal germline mosaicism. Unfortu-
nately, the father was no longer available for us to confirm
somatic and/or gonadal mosaicism by studying additional
tissues (e.g., sperm cells) or employing deep resequencing
or ultra-sensitive methodologies (i.e., quantitative real-
time PCR) to estimate the proportion of the mutated allele
[13]. It should be noted that the term “germline mosai-
cism” should not be taken as implying that the pathogenic
variation is confined to gonadal tissue; indeed, it may also
appear in somatic tissues other than the original sample
source [13, 14].
We analyzed intragenic markers in an effort to docu-
ment a common haplotype for the p.(Arg348*) variant,
as this would presumably support its origin from a single
paternal germ cell line. However, the 10 intragenic
markers located closest to the p.(Arg348*) variant (lying
between exons 5 and 25) failed to yield informative ge-
notypes, rendering us unable to integrate the phases of
NPC1 or determine the presence/absence of a variant-
linked haplotype with any certainty. Three markers lo-
cated toward the 5′ end of the NPC1 gene provided suf-
ficient information to suggest that there was a
recombination event in the paternal germline (Fig. 1).An alternative (but less likely) possibility is that the
p.(Arg348*) variant may reside in two distinct paternal
NPC1 haplotypes.
In recent years, mixed somatic and germline mosai-
cism has been recognized as an important and rela-
tively common mechanism through which genetic
disorders originate [13–15]. Such mosaicism has been
reported in diseases with autosomal-recessive inherit-
ance, including Gaucher disease (MIM#230800) [16]
and Alport syndrome (MIM#203780) [17]. In most
cases, these mutations occur via mechanisms such as
unequal homologous crossing-over, excision of intra-
chromatid loops, inadequate incorporation of nucleo-
tides during the replication process, or deamination
of 5-methylcytosine [15]. In the case of Gaucher dis-
ease, two families were recently described [16]; each
had a single affected patient, and in both cases only
the paternal mutated allele was identified in
leukocyte-derived DNA. No mutation was detected in
blood-derived DNA samples from the mother, sister,
or maternal grandmother of either proband. Maternity
was confirmed with a 99.7 % certainty in both cases,
prompting the authors to postulate that the presence
of Gaucher disease in the patients was due to mater-
nal germline mosaicism or (less likely) a de novo
p.Leu444Pro mutation in the maternal germlines of
both families [16]. These possibilities were not con-
firmed with further molecular testing, but should be
considered in the context of genetic counseling. In
the current case, based on the presence of the
c.1042C > T variant in both the patient and his
healthy sister (but not their father), we conclude that
the mutated allele was most likely to have been inher-
ited through paternal germline mosaicism (Fig. 1). It
seems far less probable that there were two de novo
mutations in the paternal germline.
In conclusion, our finding of probable germline mosai-
cism in NP-C has major clinical implications for genetic
counseling. Currently, parental DNA is not evaluated in
all cases, as exemplified by the fact that the carrier status
of both parents was not examined in the four reported
Table 1 Comparison of the clinical characteristics and genotypes of previously reported patients who share at least one mutation with the present case
Present case Meiner et al. 2001 [5] Xiong et al. 2012 [6] Jahnova et al. 2014 [7] Piña et al. 2014 [8]
Case 1 2 3 4 5 6 7
Age at onset 9 years 20 years 8.5 years 14 years (sibling
of cases 5 and 6)
27 years (sibling
of cases 4 and 6)
20 years (sibling
of cases 4 and 5)
24 years
Gender Male Male Male Male Female Female Female
Family consanguinity - + - - - - -
Progressive clumsiness + - + - - - +
VSGP + + - - - - +
Dysarthria + + + + - - -
Cataplexy + - - - - - -
Ataxia + + + - - - +
Splenomegaly + + - + + + +
Cerebellar atrophy - NR + NR NR NR +
Behavioral anomalies + - - + + + +
Depression - - - - + - +
Schizophrenia - - - - - + +
Bone marrow
aspiration
Blue histiocytes Blue histiocytes Blue histiocytes NR Blue histiocytes NR Foamy histiocytes
NP-C index suspicion
score [11] at diagnosis
142 points NR NR NR NR NR 227 points
Filipin staining “Variant”a Positive Not performed “Variant”a “Variant”a “Variant”a Positive
NPC1 genotype c.[1042C > T];[2780C > T]
or p.[Arg348*];[Ala927Val]
c.[2780C > T];[2780C > T]
or p.[Ala927Val];[Ala927Val]
c.[2777C > T];[2780C > T]
or p.[Ala926Val];[Ala927Val]
c.[2780C > T];[2780C > T]
or p.[Ala927Val];[Ala927Val]
c.[2780C > T];[2780C > T]
or p.[Ala927Val];[Ala927Val]
c.[2780C > T];[2780C > T]
or p.[Ala927Val];[Ala927Val]
c.[1042C > T];[3493G > A]
or p.[Arg348*];[Val1165Met]
Family NPC1 studies Mother and healthy
sister: obligate p.(Ala927Val)
and p.(Arg348*) carriers, respectively
Father: germline mosaicism
for c.1042C > T (p.Arg348*) variant
NR NR NR NR NR NR
aThe “variant” filipin fibroblast profile of NP-C refers to situations in which supplementation with pure low-density lipoproteins yields a less intense and non-uniform pattern of perinuclear fluorescent vesicles in cells.
This phenotype makes it impossible to establish an accurate percentage of NP-C “positive” cells. Moreover, the presence of these “variant” phenotype cells within total human serum causes the filipin staining pattern
to overlap even further with the normal to very mildly abnormal perinuclear fluorescent vesicle distribution characteristic of NP-C [4]
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identified in our patient (Table 1). Our novel finding
supports the contention that in NP-C, clinicians must
confirm the carrier status of both parents and analyze
other first-degree relatives in order to provide families
with accurate genetic counseling regarding their recur-
rence risk in future pregnancies.
Abbreviations
(-), absent; (+), present; NP-C, Niemann-Pick disease type C; NR, not reported;
rec?, probably reflects a recombination event; VSGP, vertical supranuclear
gaze paralysis
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